LXEO · Forms 3, 4, 5
Insider trades at Lexeo Therapeutics, Inc.
3 insiders sold $43K of Lexeo Therapeutics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Lexeo Therapeutics, Inc. (LXEO) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Louis Edward Tamayo | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Narinder Pal Bhalla | Chief Medical Officer | Award | 2,714 | $3.58 | $10K | Form 4 | |
| Jose Manuel Otero | Chief Operating Officer | Award | 2,110 | $2.64 | $6K | Form 4 | |
| Richard Nolan Townsend | Chief Executive Officer | Award | 2,306 | $2.64 | $6K | Form 4 | |
| Louis Edward Tamayo | Chief Financial Officer | Sell | 4,117 | $4.91 | $20K | Form 4 | |
| Richard Nolan Townsend | Chief Executive Officer | Sell | 3,345 | $4.95 | $17K | Form 4 | |
| Jose Manuel Otero | Chief Operating Officer | Sell | 1,304 | $4.96 | $6K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.